Results(4620)
MS700568_0151: An observational, multicenter, prospective, phase IV study evaluating cladribine tablets’ effects on PROs and their correlation with clinical and biometric parameters using Health Technology in subjects with highly-active RMS at their first switch (CLADFIT-MS)
Italy
EU PAS number:
EUPAS43893
First published:
01/04/2026
Study
Finalised
Frequency of HIV diagnoses among people using oral and LA PrEP (223555)
United States
EU PAS number:
EUPAS1000000371
First published:
01/04/2026
Study
Ongoing
MS100070_0031: Non-interventional cohort registry study to assess characteristics and management of patients with Merkel Cell Carcinoma in Germany (MCC-TRIM)
Germany
EU PAS number:
EUPAS25338
First published:
01/04/2026
Study
Finalised
Fezolinetant Experience for the Treatment of Vasomotor Symptoms Associated with Menopause Among Women in a German Real-life Setting
Germany
EU PAS number:
EUPAS1000000132
First published:
01/04/2026
Study
Ongoing
Prospective Observational Non-interventional Study to Describe Characteristics and Management of Patients With Giant Cell Tumor of Bone Treated With XGEVA and Its Use in Routine Clinical Practice in France (20150360)
France
EU PAS number:
EUPAS21542
First published:
01/04/2026
Study
Finalised
Interim Analysis of Myocarditis and Pericarditis Associated with COMIRNATY in Persons Less Than 21 Years of Age
Canada
United States
EU PAS number:
EUPAS1000000600
First published:
01/04/2026
Study
Cancelled
A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)
France
EU PAS number:
EUPAS1000000759
First published:
01/04/2026
Study
Ongoing
Optimum Patient Care Research Database
First published:
31/03/2026
United Kingdom
United Kingdom (Northern Ireland)
Data source
Human
Other
Primary care medical recordsRecord completeness: 100%
Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
First published:
31/03/2026
United Kingdom
Data source
Human
Disease registry
Primary care medical recordsRecord completeness: 98%
Drug-Drug Interactions Between ADHD and Cardiometabolic Medications: a Pharmacovigilance Study
Australia
Denmark
Sweden
United States
EU PAS number:
EUPAS1000000761
First published:
31/03/2026
Study
Planned
DARWIN EU® - Characterisation of acute renal outcomes and diabetic complications among patients with concomitant use of metformin and iodinated contrast agents
Denmark
Finland
Spain
United Kingdom
EU PAS number:
EUPAS1000000662
First published:
31/03/2026
Study
Finalised
ADEPT: feasibility of estimating the risk of adverse pregnancy, neonatal and child outcomes following either in utero ASM exposure through the mother, or peri-conceptional ASM exposure through the father
Finland
France
Italy
Netherlands
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000246
First published:
31/03/2026
Study
Ongoing
TAK-669-4018: A Survey Among Patients, Caregivers and Home Infusion Nurses Based in the European Union to Assess Their Awareness and Understanding of Educational Materials Supporting VPRIV® Infusion at Home
Austria
Belgium
Denmark
Finland
France
Germany
Ireland
Italy
Netherlands
Spain
EU PAS number:
EUPAS49598
First published:
31/03/2026
Study
Planned
DARWIN EU® - Characterising the incidence and presentation of myocarditis and/or pericarditis in Europe
Denmark
Finland
Germany
Netherlands
Norway
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000967
First published:
31/03/2026
Study
Ongoing
MS700568_0199: Prospective Observational Study Aimed at Evaluating Treatment Satisfaction and Effectiveness in Patients with Relapsing Multiple Sclerosis Starting CLADRibinE TAbLets (CLADREAL)
Italy
EU PAS number:
EUPAS49334
First published:
31/03/2026
Study
Ongoing
Enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, non-interventional study in Italy (EVIDENCE)
Italy
EU PAS number:
EUPAS107848
First published:
31/03/2026
Study
Ongoing
Real-world use of enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, retrospective, non-interventional study in France
France
EU PAS number:
EUPAS105591
First published:
31/03/2026
Study
Finalised
Centre for Health Protection (RIVM-GZB), National Institute for Public Health & Environment
Netherlands
First published:
30/03/2026
Institution
EU Institution/Body/Agency
Laboratory/Research/Testing facility
ENCePP partner
EMR200136_593: A Study Assessing the U.S. Post-Marketing Safety Profile of Rebif® in comparison with its U.S. Prescribing Information
United States
EU PAS number:
EUPAS7290
First published:
30/03/2026
Study
Finalised
EMR200084_512: Risk of lactic acidosis with metformin use in type 2 diabetes mellitus with renal impairment: retrospective cohort study
United Kingdom
EU PAS number:
EUPAS8658
First published:
30/03/2026
Study
Finalised
Real-World Treatment Patterns and Clinical Outcomes of BRAF V600-Mutant Metastatic Melanoma Patients Treated at Academic Oncology Centers in the United States
United States
EU PAS number:
EUPAS1000000307
First published:
30/03/2026
Study
Planned
EMR200101_502: Incidence and pattern description of gastrointestinal, skin, genital, corneal, and mucosal erosions, ulcerations, perforations, haemorrhages, fistulas, abscesses, delayed wound healing and death among patients treated with nicorandil with and without diverticular disease
United Kingdom
EU PAS number:
EUPAS13205
First published:
30/03/2026
Study
Finalised
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240216)
United States
EU PAS number:
EUPAS1000000367
First published:
30/03/2026
Study
Ongoing
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Patients and/or Caregivers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240214)
United States
EU PAS number:
EUPAS1000000368
First published:
30/03/2026
Study
Ongoing
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the Prolia Risk Evaluation and Mitigation of Strategy (REMS) (20240121)
United States
EU PAS number:
EUPAS1000000393
First published:
30/03/2026
Study
Ongoing
Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088)
Denmark
Norway
Sweden
EU PAS number:
EUPAS48452
First published:
30/03/2026
Study
Ongoing
Effect of Glucagon-Like Peptide-1 Receptor Agonists on the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy Among Older Adults with Type 2 Diabetes: A US. Medicare Active-Comparator New-User Cohort Study
United States
EU PAS number:
EUPAS1000000966
First published:
30/03/2026
Study
Ongoing
GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND OBSTRUCTIVE SLEEP APNEA RISK USING MEDICARE DATA 2007 - 2019
United States
EU PAS number:
EUPAS1000000965
First published:
30/03/2026
Study
Ongoing
Centre for Maternal, Fetal and Infant Research (MFIR), Ulster University
United Kingdom (Northern Ireland)
First published:
27/03/2026
Institution
Educational Institution
ENCePP partner
The Cancer Registry of Norway
First published:
27/03/2026
Norway
Data source
Human
Cancer registry
Disease registryRecord completeness: 97%
German Pharmacoepidemiological Research Database
First published:
27/03/2026
Germany
Data source
Human
Administrative healthcare records (e.g., claims)Record completeness: 90%
Save Sight Registries
First published:
27/03/2026
Australia
Austria
Belgium
Bosnia and Herzegovina
Canada
Egypt
Fiji
France
Germany
India
Indonesia
Ireland
Italy
Japan
Jordan
Lebanon
Mexico
Nepal
Netherlands
New Zealand
Nigeria
Portugal
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Switzerland
Taiwan
United Arab Emirates
United Kingdom
Data source
Human
Disease registry
OtherRecord completeness: 90%
Dutch Keratinocyte Cancer Collaborative
First published:
27/03/2026
Netherlands
Data source
Human
Administrative healthcare records (e.g., claims)
Disease registry
OtherRecord completeness: 94%
Assessing Long-Term Outcomes of DUPIXENT® Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyposis (AROMA)
Canada
Germany
Italy
Japan
Netherlands
United States
EU PAS number:
EUPAS41565
First published:
27/03/2026
Study
Ongoing
Comparative Effectiveness of Osteoporosis Medications Among Female Medicare Fee-For-Service (FFS) Beneficiaries in the United States (20210028)
United States
EU PAS number:
EUPAS49101
First published:
27/03/2026
Study
Finalised
Real-World Clinical Outcomes in Patients with Severe Asthma Treated with Tezepelumab: A Retrospective Observational Study of CHRONICLE and ISAR (SYNERGY)
Belgium
Brazil
Canada
Germany
Greece
Hungary
Italy
Japan
Mexico
Netherlands
Norway
Poland
Saudi Arabia
Singapore
Spain
Switzerland
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000951
First published:
27/03/2026
Study
Ongoing
Post-Approval Observational Cohort Study to Evaluate the Safety of the COMIRNATY 2023-2024 Formula in the United States
United States
EU PAS number:
EUPAS108135
First published:
26/03/2026
Study
Ongoing
Non-Interventional Postmarketing Safety Study of the COMIRNATY 2025-2026 Formula (LP.8.1) in the United States
United States
EU PAS number:
EUPAS1000000932
First published:
26/03/2026
Study
Ongoing
Compare data sources